Alan D. Palkowitz
Biochemistry, Genetics and Molecular Biology · Indiana University
Publications
57
Citations
2,012
Est. group size
—
Recurring co-author estimate
Active years
42
Publishing since 1985
- Next‐generation Alzheimer's therapeutics: target assessment and enablement at the Indiana University School of Medicine–Purdue University TREAT‐AD Center
Alzheimer s & Dementia · 2026
- From consortia discovery to biotech creation: An innovative approach to next‐gen Alzheimer's drugs
Alzheimer s & Dementia · 2026
- Evaluation of ASC as a therapeutic target for Alzheimer's disease
Alzheimer s & Dementia · 2026
- Generation and characterization of iPSC‐derived microglia for in vitro modeling of stimuli‐specific neuroimmune responses
Alzheimer s & Dementia · 2026
- Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer’s Disease Models
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer’s Disease Models
Journal of Medicinal Chemistry · 2026
- Identification of PLCγ2 activators for the treatment of Alzheimer’s disease
Alzheimer s & Dementia · 2025
- Generation and validation of anti‐TREM2 agonistic antibodies to enable the advancement of drug targets in the TREM2/DAP12 signaling pathway for the treatment of Alzheimer Disease
Alzheimer s & Dementia · 2024
- IUSM‐Purdue TREAT‐AD Center Capabilities and Strategy to Enable and Advance Novel Therapeutic Targets for the Treatment of Alzheimer’s Disease
Alzheimer s & Dementia · 2024
- Identification of PLCG2 activators for the treatment of Alzheimer’s disease
Alzheimer s & Dementia · 2024
- SHIP1 therapeutic target enablement: Identification and evaluation of inhibitors for the treatment of late‐onset Alzheimer's disease
Alzheimer s & Dementia Translational Research & Clinical Interventions · 2023
- A target enablement package for modulating the activity of PLCγ2 as a therapeutic strategy for the treatment of Alzheimer’s disease
Alzheimer s & Dementia · 2023
- Role of Animal Models in Alzheimer’s Disease Drug Development
Cambridge University Press eBooks · 2022
- IUSM-Purdue TREAT-AD Center Target Enabling Package; INPP5D (SHIP1)
Zenodo (CERN European Organization for Nuclear Research) · 2022
- A Target Enablement Package for the Inhibition of SHIP1 as a Therapeutic Strategy for the Treatment of Alzheimer’s Disease
Alzheimer s & Dementia · 2022
- Alzheimer s & Dementia×12
- Zenodo (CERN European Organization for Nuclear Research)×2
- Alzheimer s & Dementia Translational Research & Clinical Interventions×1
- Cambridge University Press eBooks×1
- bioRxiv (Cold Spring Harbor Laboratory)×1
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 9, 2026.
Claim or correct this profile